Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | Linsitinib | 19.9526 | uM | 9 | 156.25 | 46.09 | 29.00 | 206.25 | 0.1406 | -0.1929 |
| MCF 10A | Linsitinib | 3.1623 | uM | 9 | 156.25 | 46.09 | 103.00 | 206.25 | 0.4994 | 0.4506 |
| MCF 10A | Lapatinib | 0.0033113 | uM | 9 | 156.25 | 46.09 | 136.00 | 206.25 | 0.6594 | 0.6496 |
| MCF 10A | Erlotinib | 0.0033113 | uM | 9 | 156.25 | 46.09 | 193.00 | 206.25 | 0.9358 | 0.9395 |
| MCF 10A | Linsitinib | 0.1 | uM | 9 | 156.25 | 46.09 | 118.00 | 206.25 | 0.5721 | 0.5447 |
| MCF 10A | Lapatinib | 0.1 | uM | 9 | 156.25 | 46.09 | 139.00 | 206.25 | 0.6739 | 0.6663 |
| MCF 10A | 0 | uM | 9 | 156.25 | 46.09 | 242.00 | 206.25 | 1.1733 | 1.1535 | |
| MCF 10A | 17-AAG | 0.000066069 | uM | 9 | 156.25 | 46.09 | 165.00 | 206.25 | 0.8000 | 0.8039 |
| MCF 10A | 0 | uM | 9 | 156.25 | 46.09 | 178.00 | 206.25 | 0.8630 | 0.8683 | |
| MCF 10A | Linsitinib | 0.01 | uM | 9 | 156.25 | 46.09 | 440.00 | 206.25 | 2.1333 | 1.8395 |
| MCF 10A | 17-AAG | 0.1 | uM | 9 | 156.25 | 46.09 | 47.00 | 206.25 | 0.2279 | 0.0091 |
| MCF 10A | Lapatinib | 0.01 | uM | 9 | 156.25 | 46.09 | 238.00 | 206.25 | 1.1539 | 1.1369 |
| MCF 10A | Lapatinib | 0.31623 | uM | 9 | 156.25 | 46.09 | 236.00 | 206.25 | 1.1442 | 1.1286 |
| MCF 10A | 17-AAG | 0.31623 | uM | 9 | 156.25 | 46.09 | 32.00 | 206.25 | 0.1552 | -0.1553 |
| MCF 10A | Erlotinib | 0.1 | uM | 9 | 156.25 | 46.09 | 237.00 | 206.25 | 1.1491 | 1.1328 |
| MCF 10A | 0 | uM | 9 | 156.25 | 46.09 | 160.00 | 206.25 | 0.7758 | 0.7784 | |
| MCF 10A | Erlotinib | 19.9526 | uM | 9 | 156.25 | 46.09 | 38.00 | 206.25 | 0.1842 | -0.0854 |
| MCF 10A | Lapatinib | 0.031623 | uM | 9 | 156.25 | 46.09 | 269.00 | 206.25 | 1.3042 | 1.2615 |
| MCF 10A | Lapatinib | 0.0016596 | uM | 9 | 156.25 | 46.09 | 241.00 | 206.25 | 1.1685 | 1.1494 |
| MCF 10A | 17-AAG | 0.031623 | uM | 9 | 156.25 | 46.09 | 31.00 | 206.25 | 0.1503 | -0.1676 |
| MCF 10A | 0 | uM | 9 | 156.25 | 46.09 | 172.00 | 206.25 | 0.8339 | 0.8389 | |
| MCF 10A | 0 | uM | 9 | 312.50 | 96.23 | 621.00 | 823.75 | 0.7539 | 0.8257 | |
| MCF 10A | Erlotinib | 0.01 | uM | 9 | 312.50 | 96.23 | 644.00 | 823.75 | 0.7818 | 0.8472 |
| MCF 10A | 17-AAG | 0.000302 | uM | 9 | 312.50 | 96.23 | 873.00 | 823.75 | 1.0598 | 1.0378 |
| MCF 10A | Erlotinib | 0.31623 | uM | 9 | 312.50 | 96.23 | 927.00 | 823.75 | 1.1253 | 1.0777 |